1. Home
  2. AREN vs ANNX Comparison

AREN vs ANNX Comparison

Compare AREN & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AREN
  • ANNX
  • Stock Information
  • Founded
  • AREN 2016
  • ANNX 2011
  • Country
  • AREN United States
  • ANNX United States
  • Employees
  • AREN N/A
  • ANNX N/A
  • Industry
  • AREN Medical/Dental Instruments
  • ANNX Biotechnology: Pharmaceutical Preparations
  • Sector
  • AREN Health Care
  • ANNX Health Care
  • Exchange
  • AREN Nasdaq
  • ANNX Nasdaq
  • Market Cap
  • AREN 305.8M
  • ANNX 257.8M
  • IPO Year
  • AREN N/A
  • ANNX 2020
  • Fundamental
  • Price
  • AREN $6.56
  • ANNX $2.31
  • Analyst Decision
  • AREN Strong Buy
  • ANNX Strong Buy
  • Analyst Count
  • AREN 1
  • ANNX 5
  • Target Price
  • AREN $12.00
  • ANNX $13.00
  • AVG Volume (30 Days)
  • AREN 233.4K
  • ANNX 1.1M
  • Earning Date
  • AREN 08-14-2025
  • ANNX 08-14-2025
  • Dividend Yield
  • AREN N/A
  • ANNX N/A
  • EPS Growth
  • AREN N/A
  • ANNX N/A
  • EPS
  • AREN 2.74
  • ANNX N/A
  • Revenue
  • AREN $146,610,000.00
  • ANNX N/A
  • Revenue This Year
  • AREN $31.49
  • ANNX N/A
  • Revenue Next Year
  • AREN $10.00
  • ANNX N/A
  • P/E Ratio
  • AREN $2.41
  • ANNX N/A
  • Revenue Growth
  • AREN 6.81
  • ANNX N/A
  • 52 Week Low
  • AREN $0.56
  • ANNX $1.29
  • 52 Week High
  • AREN $10.05
  • ANNX $7.85
  • Technical
  • Relative Strength Index (RSI)
  • AREN 51.00
  • ANNX 46.98
  • Support Level
  • AREN $6.25
  • ANNX $2.07
  • Resistance Level
  • AREN $7.61
  • ANNX $2.71
  • Average True Range (ATR)
  • AREN 0.66
  • ANNX 0.16
  • MACD
  • AREN -0.06
  • ANNX -0.02
  • Stochastic Oscillator
  • AREN 30.27
  • ANNX 37.50

About AREN The Arena Group Holdings Inc.

The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.

About ANNX Annexon Inc.

Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.

Share on Social Networks: